样式: 排序: IF: - GO 导出 标记为已读
-
A comprehensive analysis of CD47 expression in various histological subtypes of soft tissue sarcoma: exploring novel opportunities for macrophage-directed treatments J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-17
Abstract Purpose The CD47 molecule, often referred to as the “do not eat me” signal, is frequently overexpressed in tumor cells. This signaling pathway limits phagocytosis by macrophages. Our objective was to determine CD47 abundance in various soft tissue sarcomas (STS) to investigate whether it could serve as a potential evasion mechanism for tumor cells. Additionally, we aimed to assess the prognostic
-
Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomas J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-16 Sophie Schneider, Thomas Ferte, Océane Ducharme, Léa Dousset, Sorilla Prey, Caroline Dutriaux, Emilie Gerard, Marie Beylot-Barry, Anne Pham-Ledard
-
Diffusion-weighted imaging-based radiomics model using automatic machine learning to differentiate cerebral cystic metastases from brain abscesses J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-16 Linyang Cui, Zheng Qin, Siyuan Sun, Weihua Feng, Mingyuan Hou, Dexin Yu
-
Global analysis of T-cell groups reveals immunological features and common antigen targets of digestive tract tumors J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-15 Xiaoxue Li, Yuchao Zhang, Shiwei Guo, Zhenchuan Wu, Hailong Wang, Yi Huang, Yue Wang, Mengni Qiu, Jingyu Lang, Yichuan Xiao, Yufei Zhu, Gang Jin, Landian Hu, Xiangyin Kong
-
Psoralen: a narrative review of current and future therapeutic uses J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-15 Panagis Galiatsatos, Daniella D. Maydan, Elle Macalpine, Beatrice Schleupner, Alexandra Hunter Aitchison, Andrew D. Lerner, Benjamin Levy, Aditya Halthore, William Eward
-
The antagonistic effect of FTO on METTL14 promotes AKT3 m6A demethylation and the progression of esophageal cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-15 Ran Wei, Fangfang Zhao, Lingsuo Kong, Youguang Pu, Yuanhai Li, Chunbao Zang
-
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-14 Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, Yuichi Yamada, Hirofumi Chiba, Yoshihiko Hirohashi, Toshihiko Torigoe
-
GATA6 inhibits the biological function of non-small cell lung cancer by modulating glucose metabolism J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-14 Weiwei Ju, Lijuan Lin, Qifang Zhang, Xiumei Lv, Shaohui Teng, Yu Hong, Zhixiang Shao, Hanyun Na, Shengjin Yu
-
An investigation of the effect of mindfulness-integrated cognitive behavior therapy on demoralization, body image, and sexual function in Iranian women with breast cancer: a randomized controlled trial J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-14 Mahboobeh Soleymani Moghadam, Aliakbar Parvizifard, Aliakbar Foroughi, Seyed Mojtaba Ahmadi, Negin Farshchian
-
Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-14 Li-kun Ren, Ri-shang Lu, Xiao-bin Fei, Shao-jie Chen, Peng Liu, Chang-hao Zhu, Xing Wang, Yao-zhen Pan
-
A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-13
Abstract Background Cancer-associated fibroblasts (CAF) play a critical role in promoting tumor growth, metastasis, and immune evasion. While numerous studies have investigated CAF, there remains a paucity of research on their clinical application in colorectal cancer (CRC). Methods In this study, we collected differentially expressed genes between CAF and normal fibroblasts (NF) from previous CRC
-
The long-term outcomes of local tumor destruction versus partial nephrectomy for cT1a non-clear cell renal cell carcinoma and development of prognostic nomograms J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-12 Jianhui Qiu, Ruiyi Deng, Zihou Zhao, Peidong Tian, Jingcheng Zhou
-
A pan-cancer analysis of the oncogenic and immunological roles of transglutaminase 1 (TGM1) in human cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-12 Ruicheng Wu, Dengxiong Li, Shuxia Zhang, Jie Wang, Kai Chen, Zhouting Tuo, Akira Miyamoto, Koo Han Yoo, Wuran Wei, Chi Zhang, Dechao Feng, Ping Han
-
Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-11 Fang Gao, Fengxu Liu, Jun Wang, Junfang Bi, Luoping Zhai, Dong Li
-
The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-11 Ting Zhang, Zhao-tong Wang, Zhuo Li, Shuo-xin Yin, Xun Wang, Hai-zhu Chen
-
The multiple roles of autophagy in uveal melanoma and the microenvironment J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-11 Bo Liu, Xueting Yao, Yu Shang, Jinhui Dai
-
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-11
Abstract Purpose Gene mutations drive tumor immune microenvironment (TIME) heterogeneity, in turn affecting prognosis and immunotherapy efficacy. PIK3CA is the most frequently mutated gene in breast cancer (BC), yet its relevance to BC prognosis remains controversial. Herein, we sought to determine the impact of PIK3CA mutation-driven immune genes (PDIGs) on BC prognosis in relation to TIME heterogeneity
-
Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-09
Abstract Purpose This study investigated the potential applicability and the underlying mechanisms of flavokawain C, a natural compound derived from kava extracts, in liver cancer treatment. Methods Drug distribution experiment used to demonstrate the preferential tissues enrichment of flavokawain C. Cell proliferation, apoptosis and migration effect of flavokawain C were determined by MTT, colony
-
Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-09 Yue Ding, Quan Zhou, Bo Ding, Yang Zhang, Yang Shen
-
Digital decision support for structural improvement of melanoma tumor boards: using standard cases to optimize workflow J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-08 David Hoier, Carolin Groß-Ophoff-Müller, Cindy Franklin, Michael Hallek, Esther von Stebut, Thomas Elter, Cornelia Mauch, Nicole Kreuzberg, Philipp Koll
-
Treatment of poorly differentiated neuroendocrine carcinomas of rectum and anus with chemoradiotherapy: a single-centre evaluation J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-06
Abstract Purpose Poorly differentiated neuroendocrine carcinoma (PDNEC) of the rectum and anus is a rare disease exhibiting aggressive biological behaviour, even if diagnosed early. Currently, there are no agreed standard treatment approaches and management of locally advanced (LA) and metastatic PDNEC usually follows treatments used in pulmonary neuroendocrine carcinomas because of the similarities
-
Clinical outcomes of patients with CIC-rearranged sarcoma: a single institution retrospective analysis J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-04
Abstract Purpose CIC-rearranged sarcomas represent a type of undifferentiated small round cell sarcoma (USRCS) characterized by poor survival, rapid development of chemotherapy resistance, and high rates of metastasis. We aim to contribute to the growing body of knowledge regarding diagnosis, treatment, clinical course, and outcomes for these patients. Methods This case series investigates the clinical
-
Evaluation of changes in the clinical benefits of oncology drugs over time following reimbursement using the ASCO-VF and the ESMO-MCBS J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-04 Na Ri Yoon, Young Jin Na, Jong Hwan Lee, Inmyung Song, Eui-Kyung Lee, Mi-Hai Park
-
Influence of abdominal fat distribution and inflammatory status on post-operative prognosis in non-small cell lung cancer patients: a retrospective cohort study J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-03
Abstract Purpose To evaluate the influence of visceral fat area (VFA), subcutaneous fat area (SFA), the systemic immune-inflammation index (SII) and total inflammation-based systemic index (AISI) on the postoperative prognosis of non-small cell lung cancers (NSCLC) patients. Methods 266 NSCLC patients received surgery from two academic medical centers were included. To assess the effect of abdominal
-
A rare Ewing-like small round cell tumor in prostate: a case report and literature review J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-01 Zhen Wang, Jian Ye, Junjie Hu, Nan Zhang, Yichu Yuan
-
Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-01 Zhang Mengzhen, Hou Xinwei, Tan Zeheng, Li Nan, Yang Yang, Yang Huirong, Fan Kaisi, Ding Xiaoting, Yang Liucheng, Wu Kai
-
Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-29
Abstract Purpose This review primarily aims to review the epidemiology, clinical characteristics, imaging, pathology, immunohistochemistry, diagnosis, differential diagnosis, treatment, and prognosis of Primary pulmonary myxoid sarcoma (PPMS) with EWS RNA binding protein 1::cAMP response element binding protein 1 (EWSR1::CREB1) fusion. It provides reference for the diagnosis and treatment of this disease
-
Conditional survival analysis and dynamic survival prediction for intracranial solitary-fibrous tumor/hemangiopericytoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-28 Dagang Song, Zhihao Yang, Linqiang Cai, Hua Huang, Zhiwei Gu
-
Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-28 María Paula Marks, Carla Alejandra Giménez, Luciana Isaja, Mariana Belén Vera, Francisco Raúl Borzone, Federico Pereyra-Bonnet, Leonardo Romorini, Guillermo Agustín Videla-Richardson, Norma Alejandra Chasseing, Juan Carlos Calvo, Luciano Vellón
-
Advances in the antitumor mechanisms of tripartite motif-containing protein 3 J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-27 Wei Teng, Yuanguo Ling, Zongwei Liu, Lishi Jiang, Genyuan Fu, Xingwang Zhou, Niya Long, Jian Liu, Liangzhao Chu
-
Helicobacter pylori upregulates circPGD and promotes development of gastric cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-26 Wenjun Zhao, Zhendong Yao, Jia Cao, Yun Liu, Linqi Zhu, Boneng Mao, Feilun Cui, Shihe Shao
-
A novel EIF3C-related CD8+ T-cell signature in predicting prognosis and immunotherapy response of nasopharyngeal carcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-24 Rui Li, Yikai Wang, Xin Wen, Binglin Cheng, Ruxue Lv, Ruzhen Chen, Wen Hu, Yinglei Wang, Jingwen Liu, Bingyi Lin, Haixiang Zhang, Enting Zhang, XinRan Tang
-
CSMed® wound dressing for prophylaxis and management of radiation dermatitis in breast and head–neck cancer patients: a single hospital prospective clinical trial J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-23
Abstract Purpose CSMed® wound dressing, a dressing with various herb extracts, was tested for its therapeutic effect in radiation dermatitis of breast and head-and-neck cancer patients. Methods This study included 20 breast cancer patients and 10 head-and-neck cancer patients. Half of the irradiated area was covered with CSMed® and the other half was under routine treatment. The severity of radiation
-
Machine learning predicts the risk of osteoporosis in patients with breast cancer and healthy women J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-23
Abstract Objective In this study, we investigated the effects of endocrine therapy and related drugs on the body composition and bone metabolism of patients with breast cancer. Additionally, using body composition-related indicators in machine learning algorithms, the risks of osteoporosis in patients with breast cancer and healthy women were predicted. Methods We enrolled postmenopausal patients with
-
Causal relationship between psychological factors and hepatocellular carcinoma as revealed by Mendelian randomization J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-21 Fengming Xu, Olaf Dirsch, Uta Dahmen
-
Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-21
Abstract Objective The initial therapeutic approach for diffuse large B-cell lymphoma (DLBCL) entails a rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen. However, 40% of patients exhibit suboptimal responses, with some experiencing relapse and refractory conditions. This study aimed to explore novel therapeutic strategies and elucidate their underlying mechanisms
-
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-21 Ludmila Krizova, Iva Benesova, Petra Zemanova, Jan Spacek, Zuzana Strizova, Zuzana Humlova, Veronika Mikulova, Lubos Petruzelka, Michal Vocka
-
A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent chordoma patient with molecular alterations treated with Palbociclib J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-19 Nanzhe Zhong, Dong Yu, Minglei Yang, Xingyi Lu, Qiangzu Zhang, Wei Wei, Jian Jiao, Xinghai Yang, Zhi Zhu, Su Chen, Jianru Xiao
-
TEP RNA: a new frontier for early diagnosis of NSCLC J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-19 Yuan Wang, Aiping Dong, Minhan Jin, Shirong Li, Yang Duan
-
Tumor-to-stroma cd8+ t cells ratio combined with cancer-associated fibroblasts: an innovative approach to predicting lymph node metastases of cervical cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-19 Shuangshuang Guo, Peiyu Chen, Yang Yang, Wenfei Wei, YuHua Pan, Fanke Zeng, Liangsheng Fan, Wei Wang
-
Current look at the most promising proteomic and glycomic biomarkers of bladder cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-19 Stefan Harsanyi, Kristina Kianickova, Jaroslav Katrlik, Lubos Danisovic, Stanislav Ziaran
-
Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative study of first-line EGFR-TKIs with/without upfront LT J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-19 Lishui Niu, Honghua Wu, Ruihuan Gao, Liu Chen, Jiangtao Wang, Hexin Duan, Yujiao Long, Yi Xie, Qin Zhou, Rongrong Zhou
-
Effectiveness and safety of intraoperative intraperitoneal 5-Fu drug implantation in patients with colorectal cancer: a retrospective cohort study J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-13
Abstract Purpose The purpose of this clinical study was to evaluate the efficacy and safety of intraoperative chemotherapy (IOC) with intraoperative intraperitoneal implantation of 5-fluorouracil (5-FU) in colorectal cancer (CRC) patients. Methods In this study, 165 patients who underwent colorectal radical surgery were selected, of whom 111 in the experimental group received surgical treatment with
-
Guanylate binding protein 4 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-12 Weijian Zhou, Gaoshaer Yeerkenbieke, Yumei Zhang, Mingwang Zhou, Jin Li
-
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-12 Tadahiro Kuribayashi, Kadoaki Ohashi, Kazuya Nishii, Kiichiro Ninomiya, Yukari Tsubata, Nobuhisa Ishikawa, Masahiro Kodani, Nobuhiro Kanaji, Masahiro Yamasaki, Kazunori Fujitaka, Shoichi Kuyama, Nagio Takigawa, Nobukazu Fujimoto, Tetsuya Kubota, Masaaki Inoue, Keiichi Fujiwara, Shingo Harita, Ichiro Takata, Kenji Takada, Sachi Okawa, Katsuyuki Kiura, Katsuyuki Hotta
-
An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-12 Bangjie Chen, Yanxun Han, Shuyan Sheng, Jianyi Deng, Emely Vasquez, Vicky Yau, Muzi Meng, Chenyu Sun, Tao Wang, Yu Wang, Mengfei Sheng, Tiangang Wu, Xinyi Wang, Yuchen Liu, Ning Lin, Lei Zhang, Wei Shao
-
MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial–mesenchymal transition in lung adenocarcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-10 Xiaochun Xia, Yangyang Ge, Fanghong Ge, Pei Gu, Yuanyuan Liu, Peng Li, Pengqin Xu
-
Development of a novel lncRNA-derived immune gene score using machine learning-based ensembles for predicting the survival of HCC J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-09 Qun Cai, Guoqi Li, Mingyan Zhu, Tingting Zhuo, Jiaying Xiao
-
Overexpression of aquaporin-1 plays a vital role in proliferation, apoptosis, and pyroptosis of Wilms’ tumor cells J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-09 Hong Liu, Chen Jin, Nan Xia, Qian Dong
-
Radiomics analysis of contrast-enhanced computerized tomography for differentiation of gastric schwannomas from gastric gastrointestinal stromal tumors J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-09 Cui Zhang, Chongwei Wang, Guoqun Mao, Guohua Cheng, Hongli Ji, Linyang He, Yang Yang, Hongjie Hu, Jian Wang
-
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-08 Tobias Peres, Stefanie Aeppli, Stefanie Fischer, Katrin Gysel, Christian Rothermundt
-
CircBRIP1: a plasma diagnostic marker for non-small-cell lung cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-08 Xinfeng Fan, Qi Zhang, Shiyi Qin, Shaoqing Ju
-
The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-06 Bingyu Ran, Jingjie Shang, Yong Chen, Miaoli Zhou, Huihu Li, Wenjun He, Yingxin Li, Qijun Cai, Bin Guo, Jian Gong, Hao Xu
-
Approved immune checkpoint inhibitors in hepatocellular carcinoma: a large-scale meta-analysis and systematic review J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-06 Ruyi Zhang, Fang Wang, Zhiyu You, Dongyang Deng, Jiangyan He, Wentao Yan, Jian Quan, Jing Wang, Shujuan Yan
-
The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-06 Anne Olbrich, Johannes Niemeyer, Hendrik Seiffert, Sebastian Ebel, Olga Gros, Florian Lordick, Dirk Forstmeyer, Daniel Seehofer, Sebastian Rademacher, Timm Denecke, Madlen Matz-Soja, Thomas Berg, Florian van Bömmel
-
Sd-net: a semi-supervised double-cooperative network for liver segmentation from computed tomography (CT) images J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-05
Abstract Introduction The automatic segmentation of the liver is a crucial step in obtaining quantitative biomarkers for accurate clinical diagnosis and computer-aided decision support systems. This task is challenging due to the frequent presence of noise and sampling artifacts in computerized tomography (CT) images, as well as the complex background, variable shapes, and blurry boundaries of the
-
Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-05 Chaoxiang Du, Lijie Tan, Xiao Xiao, Beibei Xin, Hui Xiong, Yuying Zhang, Zhonghe Ke, Jun Yin
-
Deep learning algorithm-based multimodal MRI radiomics and pathomics data improve prediction of bone metastases in primary prostate cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-05 Yun-Feng Zhang, Chuan Zhou, Sheng Guo, Chao Wang, Jin Yang, Zhi-Jun Yang, Rong Wang, Xu Zhang, Feng-Hai Zhou
-
Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-04 Johannes Stein, Eliana Krappe, Anika Kremer, Marcus V. Cronauer, Markus Essler, Alexander Cox, Niklas Klümper, Philipp Krausewitz, Jörg Ellinger, Manuel Ritter, Glen Kristiansen, Michael Majores
-
Exploring reciprocal causation: bidirectional mendelian randomization study of gut microbiota composition and thyroid cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-02-03 Jiating Zhou, Xuan Zhang, Zilan Xie, Zhi Li